| 1 |
32885355 |
10.1007/s10637-020-00996-1 |
2022 |
The anti-malaria agent artesunate exhibits cytotoxic effects in primary effusion lymphoma. |
JUNB |
| 2 |
34303663 |
10.1016/j.ejphar.2021.174373 |
2022 |
The antipsychotic drug pimozide is effective against human T-cell leukemia virus type 1-infected T cells. |
JUNB |
| 3 |
34818414 |
10.1182/blood.2021012734 |
2022 |
Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma. |
JUNB |
| 4 |
36045346 |
10.1186/s12943-022-01640-7 |
2022 |
PDGFRβ promotes oncogenic progression via STAT3/STAT5 hyperactivation in anaplastic large cell lymphoma. |
JUNB |
| 5 |
31935288 |
10.1182/bloodadvances.2019000947 |
2021 |
Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas. |
JUNB |
| 6 |
32299901 |
10.3324/haematol.2019.241307 |
2021 |
miR-939 acts as tumor suppressor by modulating JUNB transcriptional activity in pediatric anaplastic large cell lymphoma. |
JUNB |
| 7 |
32780889 |
10.1111/ejh.13508 |
2021 |
The role of CUDC-907, a dual phosphoinositide-3 kinase and histone deacetylase inhibitor, in inhibiting proliferation of adult T-cell leukemia. |
JUNB |
| 8 |
33821477 |
10.1002/ijc.33584 |
2021 |
A rare variant in EZH2 is associated with prostate cancer risk. |
JUNB |
| 9 |
34277639 |
10.3389/fcell.2021.693706 |
2021 |
HIV-1 Transactivator of Transcription (Tat) Co-operates With AP-1 Factors to Enhance <i>c-MYC</i> Transcription. |
JUNB |
| 10 |
30213827 |
10.3324/haematol.2018.203224 |
2020 |
<i>JUNB</i>, <i>DUSP2</i>, <i>SGK1</i>, <i>SOCS1</i> and <i>CREBBP</i> are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma. |
JUNB |
| 11 |
31577659 |
10.1097/PRS.0000000000006390 |
2020 |
Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder? |
JUNB |
| 12 |
31996318 |
10.1016/j.ejphar.2020.172953 |
2020 |
Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma. |
JUNB |
| 13 |
28879465 |
10.1007/s00292-017-0335-4 |
2019 |
[Nodular lymphocyte-dominant Hodgkin's lymphoma : LP cells show recurrent mutations in DUSP2, SGK1 and JUNB]. |
JUNB |
| 14 |
29689246 |
10.1016/j.humpath.2018.04.007 |
2019 |
IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis. |
JUNB |
| 15 |
30375407 |
10.1038/s41598-018-34199-9 |
2019 |
The c-Jun and JunB transcription factors facilitate the transit of classical Hodgkin lymphoma tumour cells through G<sub>1</sub>. |
JUNB |
| 16 |
27340921 |
10.18632/oncotarget.10210 |
2018 |
Impact of the SCF signaling pathway on leukemia stem cell-mediated ATL initiation and progression in an HBZ transgenic mouse model. |
JUNB |
| 17 |
27600282 |
10.1007/s10238-016-0436-z |
2018 |
Expression patterns of the activator protein-1 (AP-1) family members in lymphoid neoplasms. |
JUNB |
| 18 |
27793034 |
10.18632/oncotarget.12876 |
2018 |
Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes. |
JUNB |
| 19 |
28586006 |
10.3892/ijo.2017.4026 |
2018 |
Butein inhibits NF-κB, AP-1 and Akt activation in adult T-cell leukemia/lymphoma. |
JUNB |
| 20 |
28659618 |
10.1038/leu.2017.203 |
2018 |
An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma. |
JUNB |
| 21 |
28976960 |
10.1038/nature24037 |
2018 |
Cancer drug addiction is relayed by an ERK2-dependent phenotype switch. |
JUNB |
| 22 |
29048633 |
10.3892/or.2017.5978 |
2018 |
In vitro and in vivo anti-primary effusion lymphoma activities of fucoidan extracted from Cladosiphon okamuranus Tokida. |
JUNB |
| 23 |
29901068 |
10.3892/ijo.2018.4427 |
2018 |
Mitotic kinase PBK/TOPK as a therapeutic target for adult T‑cell leukemia/lymphoma. |
JUNB |
| 24 |
26133723 |
10.3109/10428194.2015.1068306 |
2017 |
Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma. |
JUNB |
| 25 |
26979456 |
10.1093/asj/sjw023 |
2017 |
Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma. |
JUNB |
| 26 |
20302775 |
|
2016 |
[Expression and function of TRAF1 in Hodgkin's lymphoma cells.]. |
JUNB |
| 27 |
25813203 |
10.3109/10428194.2015.1034704 |
2016 |
The expression levels of JunB, JunD and p-c-Jun are positively correlated with tumor cell proliferation in diffuse large B-cell lymphomas. |
JUNB |
| 28 |
25987255 |
10.1038/leu.2015.127 |
2016 |
Constitutive control of AKT1 gene expression by JUNB/CJUN in ALK+ anaplastic large-cell lymphoma: a novel crosstalk mechanism. |
JUNB |
| 29 |
26045176 |
10.1016/j.joca.2015.05.011 |
2016 |
Distinctive pro-inflammatory gene signatures induced in articular chondrocytes by oncostatin M and IL-6 are regulated by Suppressor of Cytokine Signaling-3. |
JUNB |
| 30 |
26658840 |
10.1038/leu.2015.328 |
2016 |
Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma. |
JUNB |
| 31 |
26725775 |
10.1016/j.leukres.2015.11.016 |
2016 |
miRNA-149* promotes cell proliferation and suppresses apoptosis by mediating JunB in T-cell acute lymphoblastic leukemia. |
JUNB |
| 32 |
26747248 |
10.1182/blood-2015-07-655647 |
2016 |
CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas. |
JUNB |
| 33 |
24850846 |
10.1158/1078-0432.CCR-14-0307 |
2015 |
Ectopic expression of cancer-testis antigens in cutaneous T-cell lymphoma patients. |
JUNB |
| 34 |
25013898 |
10.1371/journal.pone.0100822 |
2015 |
Reliable quantification of protein expression and cellular localization in histological sections. |
JUNB |
| 35 |
25145835 |
10.1111/bjh.13079 |
2015 |
The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma. |
JUNB |
| 36 |
25444930 |
10.1016/j.canlet.2014.11.019 |
2015 |
Lobatin B inhibits NPM/ALK and NF-κB attenuating anaplastic-large-cell-lymphomagenesis and lymphendothelial tumour intravasation. |
JUNB |
| 37 |
25533033 |
10.1182/blood-2014-04-568188 |
2015 |
Jun-regulated genes promote interaction of diffuse large B-cell lymphoma with the microenvironment. |
JUNB |
| 38 |
25961698 |
10.2741/S436 |
2015 |
The role of AP-1 and epigenetics in ALCL. |
JUNB |
| 39 |
26220634 |
10.1016/j.phymed.2015.06.003 |
2015 |
The germacranolide sesquiterpene lactone neurolenin B of the medicinal plant Neurolaena lobata (L.) R.Br. ex Cass inhibits NPM/ALK-driven cell expansion and NF-κB-driven tumour intravasation. |
JUNB |
| 40 |
23716562 |
10.3324/haematol.2012.081935 |
2014 |
CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features. |
JUNB |
| 41 |
24018901 |
10.3390/md11093410 |
2014 |
Hippuristanol reduces the viability of primary effusion lymphoma cells both in vitro and in vivo. |
JUNB |
| 42 |
24750504 |
10.1111/apm.12249 |
2014 |
ALK gene aberrations and the JUN/JUNB/PDGFR axis in metastatic NSCLC. |
JUNB |
| 43 |
24872589 |
10.1128/JVI.01094-14 |
2014 |
Human T-cell leukemia virus type 3 (HTLV-3) and HTLV-4 antisense-transcript-encoded proteins interact and transactivate Jun family-dependent transcription via their atypical bZIP motif. |
JUNB |
| 44 |
22710716 |
10.1038/onc.2012.235 |
2013 |
GSK3-SCF(FBXW7) targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase. |
JUNB |
| 45 |
22980495 |
10.1179/1607845412Y.0000000028 |
2013 |
Alteration of the gene expression profile of T-cell receptor αβ-modified T-cells with diffuse large B-cell lymphoma specificity. |
JUNB |
| 46 |
23064464 |
10.1038/nm.2966 |
2013 |
PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas. |
JUNB |
| 47 |
23135783 |
10.3892/ijo.2012.1690 |
2013 |
The dichloromethane extract of the ethnomedicinal plant Neurolaena lobata inhibits NPM/ALK expression which is causal for anaplastic large cell lymphomagenesis. |
JUNB |
| 48 |
23246696 |
10.1016/j.gene.2012.12.009 |
2013 |
Regulation of the MIR155 host gene in physiological and pathological processes. |
JUNB |
| 49 |
23749999 |
10.1074/jbc.M113.485672 |
2013 |
Cleavage of the JunB transcription factor by caspases generates a carboxyl-terminal fragment that inhibits activator protein-1 transcriptional activity. |
JUNB |
| 50 |
22107829 |
10.1016/j.ajpath.2011.10.007 |
2012 |
Ets-1 activates overexpression of JunB and CD30 in Hodgkin's lymphoma and anaplastic large-cell lymphoma. |
JUNB |
| 51 |
22414602 |
10.1016/j.ajpath.2012.01.008 |
2012 |
MicroRNA 96 is a post-transcriptional suppressor of anaplastic lymphoma kinase expression. |
JUNB |
| 52 |
22465179 |
10.1016/j.bbagen.2012.03.009 |
2012 |
Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia. |
JUNB |
| 53 |
22553204 |
10.1074/jbc.M112.340992 |
2012 |
Tax protein-induced expression of antiapoptotic Bfl-1 protein contributes to survival of human T-cell leukemia virus type 1 (HTLV-1)-infected T-cells. |
JUNB |
| 54 |
22681779 |
10.1186/1471-2407-12-229 |
2012 |
The heat shock protein-90 co-chaperone, Cyclophilin 40, promotes ALK-positive, anaplastic large cell lymphoma viability and its expression is regulated by the NPM-ALK oncoprotein. |
JUNB |
| 55 |
20559121 |
10.1097/DAD.0b013e3181cfbfbf |
2011 |
Histopathologic diagnosis of lymphomatous versus inflammatory erythroderma: a morphologic and phenotypic study on 47 skin biopsies. |
JUNB |
| 56 |
21190961 |
10.1210/en.2010-0790 |
2011 |
The transcription factor B-cell lymphoma (BCL)-6 modulates pancreatic {beta}-cell inflammatory responses. |
JUNB |
| 57 |
21219881 |
10.1016/j.bcp.2010.12.025 |
2011 |
Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia. |
JUNB |
| 58 |
21318218 |
10.3892/ijo.2011.939 |
2011 |
Anti-adult T-cell leukemia effects of Bidens pilosa. |
JUNB |
| 59 |
21326808 |
|
2011 |
NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphoma. |
JUNB |
| 60 |
21741362 |
10.1016/j.bbrc.2011.06.157 |
2011 |
Involvement of Cot activity in the proliferation of ALCL lymphoma cells. |
JUNB |
| 61 |
19550297 |
10.1097/PAI.0b013e3181a307f7 |
2010 |
Utility of fascin and JunB in distinguishing nodular lymphocyte predominant from classical lymphocyte-rich Hodgkin lymphoma. |
JUNB |
| 62 |
19912218 |
10.1111/j.1365-2141.2009.07977.x |
2010 |
Peripheral T-cell lymphoma gene expression profiling and potential therapeutic exploitations. |
JUNB |
| 63 |
20087027 |
|
2010 |
[Mechanism of oncogenesis by human T-cell leukemia virus type 1]. |
JUNB |
| 64 |
20132737 |
10.5483/bmbrep.2010.43.1.057 |
2010 |
Over-expression of JunB inhibits mitochondrial stress and cytotoxicity in human lymphoma cells exposed to chronic oxidative stress. |
JUNB |
| 65 |
20448669 |
10.1038/cgt.2010.20 |
2010 |
Synergistic growth inhibition of anaplastic large cell lymphoma cells by combining cellular ALK gene silencing and a low dose of the kinase inhibitor U0126. |
JUNB |
| 66 |
18494816 |
10.1111/j.1600-0560.2007.00924.x |
2009 |
A genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS. |
JUNB |
| 67 |
19064921 |
10.1073/pnas.0810965105 |
2009 |
Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL. |
JUNB |
| 68 |
19307668 |
10.1182/blood-2008-12-193037 |
2009 |
The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL. |
JUNB |
| 69 |
19321746 |
10.1073/pnas.0900912106 |
2009 |
Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma. |
JUNB |
| 70 |
19339050 |
10.1016/j.leukres.2009.03.003 |
2009 |
c-Jun N-terminal kinase 2 (JNK2) antagonizes the signaling of differentiation by JNK1 in human myeloid leukemia cells resistant to vitamin D. |
JUNB |
| 71 |
17725669 |
10.1111/j.1365-2133.2007.08150.x |
2008 |
Abnormal activator protein 1 transcription factor expression in CD30-positive cutaneous large-cell lymphomas. |
JUNB |
| 72 |
17951530 |
10.1182/blood-2007-04-087734 |
2008 |
Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas. |
JUNB |
| 73 |
17965727 |
10.1038/labinvest.3700696 |
2008 |
Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma. |
JUNB |
| 74 |
18071306 |
10.1038/sj.onc.1210984 |
2008 |
Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia. |
JUNB |
| 75 |
18460027 |
10.1111/j.1365-2133.2008.08579.x |
2008 |
Abnormal AP-1 protein expression in primary cutaneous B-cell lymphomas. |
JUNB |
| 76 |
18641027 |
10.3324/haematol.12875 |
2008 |
Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization. |
JUNB |
| 77 |
18717876 |
10.1111/j.1365-4632.2008.03573.x |
2008 |
Interaction between BCL2 and JUNB in primary cutaneous lymphoma: a gene ontology approach. |
JUNB |
| 78 |
17297445 |
10.1038/sj.onc.1210285 |
2007 |
JunB is a gatekeeper for B-lymphoid leukemia. |
JUNB |
| 79 |
17407586 |
10.1186/1476-4598-6-27 |
2007 |
Some facts and thoughts: p73 as a tumor suppressor gene in the network of tumor suppressors. |
JUNB |
| 80 |
17446175 |
10.1074/jbc.M607313200 |
2007 |
CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis. |
JUNB |
| 81 |
17690253 |
10.1182/blood-2007-02-071258 |
2007 |
The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling. |
JUNB |
| 82 |
16982741 |
10.1158/0008-5472.CAN-05-4101 |
2006 |
The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner. |
JUNB |
| 83 |
15507668 |
10.1016/S1525-1578(10)60525-9 |
2005 |
Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma. |
JUNB |
| 84 |
15920551 |
10.1038/modpathol.3800419 |
2005 |
JunB expression is a common feature of CD30+ lymphomas and lymphomatoid papulosis. |
JUNB |
| 85 |
16140928 |
10.1158/0008-5472.CAN-05-0925 |
2005 |
JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma. |
JUNB |
| 86 |
12907453 |
10.1182/blood-2003-03-0915 |
2004 |
JunB inhibits proliferation and transformation in B-lymphoid cells. |
JUNB |
| 87 |
14747844 |
10.1358/dnp.2003.16.10.829295 |
2004 |
The biological basis of Hodgkin's lymphoma. |
JUNB |
| 88 |
15251128 |
10.1016/j.coph.2004.02.007 |
2004 |
The role of CD30 in the pathogenesis of haematopoietic malignancies. |
JUNB |
| 89 |
15377339 |
10.1111/j.1365-2133.2004.06106.x |
2004 |
BCL2 and JUNB abnormalities in primary cutaneous lymphomas. |
JUNB |
| 90 |
12152998 |
10.1080/10428190290026358 |
2003 |
Gene expression profiling in chronic myeloid leukemia patients treated with hydroxyurea. |
JUNB |
| 91 |
12393503 |
10.1182/blood-2002-08-2434 |
2003 |
Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas. |
JUNB |
| 92 |
12696066 |
10.1002/gcc.10184 |
2003 |
Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma. |
JUNB |
| 93 |
12875982 |
10.1016/S0002-9440(10)63690-5 |
2003 |
AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells. |
JUNB |
| 94 |
12925224 |
10.1046/j.1523-1747.2003.12406.x |
2003 |
Genomic alterations in blastic natural killer/extranodal natural killer-like T cell lymphoma with cutaneous involvement. |
JUNB |
| 95 |
12145210 |
10.1093/emboj/cdf389 |
2002 |
Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. |
JUNB |
| 96 |
12165517 |
10.4049/jimmunol.169.4.1922 |
2002 |
Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene. |
JUNB |
| 97 |
12203778 |
10.1002/gcc.10104 |
2002 |
Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: identification of common genomic alterations in disease pathogenesis. |
JUNB |
| 98 |
10679065 |
10.4049/jimmunol.164.5.2311 |
2000 |
Identification of a membrane Ig-induced p38 mitogen-activated protein kinase module that regulates cAMP response element binding protein phosphorylation and transcriptional activation in CH31 B cell lymphomas. |
JUNB |
| 99 |
8833659 |
10.1210/mend.10.3.8833659 |
1997 |
Role of c-jun induction in the glucocorticoid-evoked apoptotic pathway in human leukemic lymphoblasts. |
JUNB |
| 100 |
8954114 |
10.1006/bbrc.1996.1788 |
1997 |
Cyclosporin A enhances the calcium-dependent induction of AP-1 complex and c-fos mRNA in a T cell lymphoma. |
JUNB |
Datasets
Models
